`

Kymab Ltd

Biotechnology Research

Specialities :
Advanced human antibody drug discovery and development
Drug discovery
Fully human monoclonal antibodies
And drug development
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$9.0M
size-icon Size
51 - 200

Frequently Asked Questions About Kymab Ltd

What does Kymab ltd do?+

Kymab, a Sanofi company, is a clinical-stage global biopharmaceutical company focused on the discovery and development of fully human monoclonal antibody drugs using its proprietary antibody platform which contains a full diversity of human antibodies, making it the most comprehensive antibody development platform available. Kymabs platform has been designed to maximise the diversity of human antibodies produced in response to immunisation with antigens. Selecting from a broad diversity of fully human antibodies assures the highest probability of finding drug candidates with best-in-class characteristics quickly and efficiently

What are Kymab ltd's specialties? +

Advanced human antibody drug discovery and development,drug discovery,fully human monoclonal antibodies,and drug development

What is Kymab ltd's industry? +

Kymab ltd operates in the Biotechnology research industry.

What is Kymab ltd's revenue? +

Kymab ltd's revenue is 11m - 100m

What is Kymab ltd's company size? +

Kymab ltd has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.